State Street’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09B Buy
1,843,963
+1,552
+0.1% +$773K 0.04% 369
2025
Q4
$898M Sell
1,842,411
-80,198
-4% -$37.3M 0.03% 418
2025
Q3
$806M Sell
1,922,609
-244,902
-11% -$82.4M 0.03% 445
2025
Q2
$623M Sell
2,167,511
-63,197
-3% -$18.9M 0.02% 495
2025
Q1
$688M Buy
2,230,708
+30,714
+1% +$10.5M 0.03% 455
2024
Q4
$776M Sell
2,199,994
-38,230
-2% -$14.1M 0.03% 440
2024
Q3
$802M Sell
2,238,224
-56,009
-2% -$18.9M 0.03% 425
2024
Q2
$731M Buy
2,294,233
+359,114
+19% +$95M 0.03% 433
2024
Q1
$445M Sell
1,935,119
-12,058
-0.6% -$2.72M 0.02% 555
2023
Q4
$428M Buy
1,947,177
+67,907
+4% +$15.7M 0.02% 547
2023
Q3
$424M Buy
1,879,270
+3,512
+0.2% +$809K 0.02% 520
2023
Q2
$414M Buy
1,875,758
+80,656
+4% +$17.9M 0.02% 544
2023
Q1
$402M Buy
1,795,102
+245,747
+16% +$60.6M 0.02% 548
2022
Q4
$431M Sell
1,549,355
-46,662
-3% -$11.8M 0.03% 518
2022
Q3
$334M Buy
1,596,017
+24,822
+2% +$5.55M 0.02% 567
2022
Q2
$370M Sell
1,571,195
-55,296
-3% -$11.2M 0.02% 554
2022
Q1
$292M Buy
1,626,491
+109,226
+7% +$20.8M 0.01% 692
2021
Q4
$328M Buy
1,517,265
+54,462
+4% +$10.7M 0.02% 650
2021
Q3
$270M Buy
1,462,803
+4,752
+0.3% +$936K 0.01% 700
2021
Q2
$262M Buy
1,458,051
+77,964
+6% +$14.8M 0.01% 726
2021
Q1
$231M Sell
1,380,087
-159,395
-10% -$26.6M 0.01% 732
2020
Q4
$234M Buy
1,539,482
+30,491
+2% +$4M 0.01% 697
2020
Q3
$152M Sell
1,508,991
-4,652
-0.3% -$510K 0.01% 775
2020
Q2
$183M Sell
1,513,643
-402,889
-21% -$45.3M 0.01% 684
2020
Q1
$182M Buy
1,916,532
+21,707
+1% +$2.06M 0.02% 635
2019
Q4
$167M Buy
1,894,825
+18,776
+1% +$1.65M 0.01% 770
2019
Q3
$150M Buy
1,876,049
+38,132
+2% +$3.07M 0.01% 797
2019
Q2
$143M Sell
1,837,917
-384,021
-17% -$35.9M 0.01% 828
2019
Q1
$261M Buy
2,221,938
+265,561
+14% +$30.9M 0.02% 603
2018
Q4
$213M Sell
1,956,377
-112,533
-5% -$13M 0.02% 613
2018
Q3
$265M Buy
2,068,910
+74,906
+4% +$9.27M 0.02% 607
2018
Q2
$226M Sell
1,994,004
-100,423
-5% -$11M 0.02% 649
2018
Q1
$235M Buy
2,094,427
+172,870
+9% +$22M 0.02% 632
2017
Q4
$284M Sell
1,921,557
-170,574
-8% -$21.7M 0.02% 572
2017
Q3
$245M Buy
2,092,131
+77,625
+4% +$9.91M 0.02% 605
2017
Q2
$261M Buy
2,014,506
+17,179
+0.9% +$2.14M 0.02% 580
2017
Q1
$270M Buy
1,997,327
+140,949
+8% +$21.4M 0.02% 569
2016
Q4
$266M Sell
1,856,378
-111,237
-6% -$14.2M 0.03% 557
2016
Q3
$232M Sell
1,967,615
-450
-0% -$54.1K 0.02% 578
2016
Q2
$208M Buy
1,968,065
+121,355
+7% +$13.5M 0.02% 597
2016
Q1
$206M Buy
1,846,710
+105,824
+6% +$13.4M 0.02% 597
2015
Q4
$273M Buy
1,740,886
+134,311
+8% +$19.6M 0.03% 510
2015
Q3
$211M Buy
1,606,575
+31,298
+2% +$5.02M 0.02% 564
2015
Q2
$274M Buy
1,575,277
+200,688
+15% +$36.1M 0.03% 514
2015
Q1
$237M Buy
1,374,589
+29,501
+2% +$4.5M 0.02% 560
2014
Q4
$174M Sell
1,345,088
-15,644
-1% -$2.02M 0.02% 649
2014
Q3
$175M Sell
1,360,732
-22,954
-2% -$2.37M 0.02% 628
2014
Q2
$122M Sell
1,383,686
-45,923
-3% -$4.42M 0.01% 785
2014
Q1
$134M Sell
1,429,609
-32,508
-2% -$3.32M 0.02% 727
2013
Q4
$165M Sell
1,462,117
-134,153
-8% -$12.1M 0.02% 645
2013
Q3
$126M Buy
1,596,270
+4,832
+0.3% +$353K 0.02% 722
2013
Q2
$105M Buy
+1,591,438
New +$103M 0.01% 766

Other funds holding UTHR